XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/news/clinical-monitoring-in-medical-device-trials-what-defines-quality-in-monitoring-5990188-2/20%Daily2018-07-18 12:32
https://www.clinicaltrialsarena.com/news/capricor-conduct-new-trial-duchenne-muscular-dystrophy/20%Daily2017-11-30 00:00
https://www.clinicaltrialsarena.com/news/g1-therapeutics-initiate-phase-ib-ii-trial-lung-cancer/20%Daily2017-11-30 00:00
https://www.clinicaltrialsarena.com/news/novartis-reports-positive-phase-iii-data-erenumab-migraine/20%Daily2017-11-30 00:00
https://www.clinicaltrialsarena.com/comment/cases-dme-among-diabetic-retinopathy-population-increase/20%Daily2017-11-29 16:27
https://www.clinicaltrialsarena.com/news/expert-insights-celgene-scraps-crohns-phase-iii-trial-for-mongersen-5989535-2/20%Daily2018-07-18 12:27
https://www.clinicaltrialsarena.com/news/viiv-healthcare-launches-phase-iii-combination-trial-hiv/20%Daily2017-11-29 00:00
https://www.clinicaltrialsarena.com/news/takeda-advances-zika-vaccine-candidate-phase-trial/20%Daily2017-11-29 00:00
https://www.clinicaltrialsarena.com/news/auckland-uniservices-supply-cytisine-achieves-rauora-trial/20%Daily2017-11-29 00:00
https://www.clinicaltrialsarena.com/comment/addressing-sub-optimal-clinical-trial-design-pancreatic-cancer/20%Daily2017-11-28 17:08
https://www.clinicaltrialsarena.com/news/considering-how-trial-sponsors-can-work-better-with-investigate-sites-utilizing-new-technologies-5988335-2/20%Daily2018-07-18 12:26
https://www.clinicaltrialsarena.com/comment/gut-microbiome-ultimate-immuno-oncology-drug-response-biomarker/20%Daily2017-11-28 10:57
https://www.clinicaltrialsarena.com/news/bayers-amikacin-fails-meet-endpoints-phase-iii-trial/20%Daily2017-11-28 00:00
https://www.clinicaltrialsarena.com/news/biohaven-concludes-enrolment-bhv3000-302-trial-migraine/20%Daily2017-11-28 00:00
https://www.clinicaltrialsarena.com/news/university-illinois-initiates-phase-ib-brain-cancer-trial/20%Daily2017-11-28 00:00
https://www.clinicaltrialsarena.com/comment/chemotherapy-induced-conditions-major-burden-cancer-patients/20%Daily2017-11-27 16:49
https://www.clinicaltrialsarena.com/news/icl-evaluates-pembrolizumab-rare-pregnancy-cancer/20%Daily2017-11-27 00:00
https://www.clinicaltrialsarena.com/news/paradigm-provides-positive-phase-iia-data-pentosan-polysulfate/20%Daily2017-11-27 00:00
https://www.clinicaltrialsarena.com/news/cancer-research-uk-studies-astrazenecas-oncology-drug/20%Daily2017-11-27 00:00
https://www.clinicaltrialsarena.com/news/postmarketing-considerations-for-the-us-5985737-2/20%Daily2018-07-18 12:25
https://www.clinicaltrialsarena.com/news/deals-week-zensun-sci-tech-co-ltd-onconova-therapeutics-inc/20%Daily2021-11-22 10:00
https://www.clinicaltrialsarena.com/news/diamedica-start-phase-ii-ischemic-stroke-trial-australia/20%Daily2017-11-24 00:00
https://www.clinicaltrialsarena.com/news/mas-week-cerecor-inc-body-mind-inc/20%Daily2017-11-24 00:00
https://www.clinicaltrialsarena.com/news/prometic-announces-positive-interim-phase-iii-data-ivig/20%Daily2017-11-24 00:00
https://www.clinicaltrialsarena.com/news/tizianas-milciclib-meets-primary-endpoint-phase-ii-trials/20%Daily2017-11-24 00:00
https://www.clinicaltrialsarena.com/comment/acorda-scraps-parkinsons-candidate-tozadenant-five-patient-deaths/20%Daily2017-11-23 12:15
https://www.clinicaltrialsarena.com/comment/parkinsons-disease-averting-looming-pandemic/20%Daily2017-11-23 10:40
https://www.clinicaltrialsarena.com/news/industry-viewpoints-pharma-economics-rarely-considered-in-development-says-expert-5984909-2/20%Daily2018-07-18 12:24
https://www.clinicaltrialsarena.com/news/khondrion-reports-favourable-phase-ii-results-kh176/20%Daily2017-11-23 00:00
https://www.clinicaltrialsarena.com/news/catalyst-pharma-begins-phase-ii-spinal-muscular-atrophy-trial/20%Daily2017-11-23 00:00
https://www.clinicaltrialsarena.com/news/arqule-commences-dosing-trial-cholangiocarcinoma/20%Daily2021-11-26 04:21
https://www.clinicaltrialsarena.com/news/precision-medicine-and-the-need-for-replication-5983438-2/20%Daily2018-09-11 07:28
https://www.clinicaltrialsarena.com/news/abivax-starts-enrolment-phase-iia-ulcerative-colitis-trial/20%Daily2017-11-22 00:00
https://www.clinicaltrialsarena.com/news/nevakar-initiates-dosing-phase-iii-myopia-trial-children/20%Daily2017-11-22 00:00
https://www.clinicaltrialsarena.com/news/daiichi-sankyo-begins-phase-ii-trial-gastric-cancer/20%Daily2017-11-22 00:00
https://www.clinicaltrialsarena.com/comment/varubi-ivs-fda-second-try-approval-provides-cinv-patients-new-option/20%Daily2017-11-21 10:40
https://www.clinicaltrialsarena.com/news/ctas-black-friday-offer-5982590-2/20%Daily2018-07-18 12:23
https://www.clinicaltrialsarena.com/news/roches-haemophilia-drug-meets-endpoints-phase-iii-trial/20%Daily2017-11-21 00:00
https://www.clinicaltrialsarena.com/news/umecrine-begins-enrolment-phase-iia-hypersomnia-trial/20%Daily2017-11-21 00:00
https://www.clinicaltrialsarena.com/news/galapagos-reports-phase-ii-data-cystic-fibrosis-drug/20%Daily2017-11-21 00:00
https://www.clinicaltrialsarena.com/comment/burden-multiple-sclerosis-twice-high-women/20%Daily2019-08-09 08:37
https://www.clinicaltrialsarena.com/news/aerie-pharma-starts-phase-ii-trial-ophthalmic-disorders/20%Daily2017-11-20 00:00
https://www.clinicaltrialsarena.com/news/celldex-starts-phase-ii-trial-head-neck-cancer/20%Daily2017-11-20 00:00
https://www.clinicaltrialsarena.com/news/us-seattle-childrens-begins-immunotherapy-trial-leukaemia/20%Daily2017-11-20 00:00
https://www.clinicaltrialsarena.com/news/expert-insights-juno-therapeutics-explores-car-t-trial-deaths-5974572-2/20%Daily2018-07-18 12:21
https://www.clinicaltrialsarena.com/news/rafael-pharma-launches-phase-pancreatic-cancer-trial/20%Daily2017-11-17 00:00
https://www.clinicaltrialsarena.com/news/mas-week-court-square-capital-partners-quotient-sciences-limited-jinzi-ham/20%Daily2017-11-17 00:00
https://www.clinicaltrialsarena.com/news/sobi-enrols-first-patient-phase-iii-trial-stills-disease/20%Daily2017-11-17 00:00
https://www.clinicaltrialsarena.com/news/deals-week-alnylam-pharmaceuticals-myovant-sciences-denali-therapeutics/20%Daily2017-11-17 00:00
https://www.clinicaltrialsarena.com/news/incyte-begins-phase-ii-trial-essential-thrombocythemia/20%Daily2017-11-17 00:00
https://www.clinicaltrialsarena.com/comment/abilify-mycite-first-digital-pill-approved/20%Daily2017-11-16 15:19
https://www.clinicaltrialsarena.com/comment/japan-will-fastest-growing-prevalent-cases-alzheimers/20%Daily2017-11-16 15:05
https://www.clinicaltrialsarena.com/news/gmp-compliance-in-multi-use-facilities-defining-strategies-to-maximize-usage-from-pilot-gmp-facilities-5973991-2/20%Daily2018-07-18 12:20
https://www.clinicaltrialsarena.com/news/promiuss-sumatriptan-meets-primary-endpoint-migraine/20%Daily2017-11-16 00:00
https://www.clinicaltrialsarena.com/news/tapimmune-enrols-last-subject-phase-ii-breast-cancer-trial/20%Daily2017-11-16 00:00
https://www.clinicaltrialsarena.com/news/sangamo-begins-sb-913-dosing-phase-iii-trial-mps-ii/20%Daily2017-11-16 00:00
https://www.clinicaltrialsarena.com/comment/future-orphan-drugs-europe/20%Daily2017-11-15 11:36
https://www.clinicaltrialsarena.com/comment/innovative-trial-design-regulators-payers-divide/20%Daily2017-11-15 11:25
https://www.clinicaltrialsarena.com/comment/industry-viewpoints-examining-the-challenges-posed-by-the-mdr-5972552-2/20%Daily2018-12-12 10:47
https://www.clinicaltrialsarena.com/news/seres-study-microbiome-therapy-immuno-oncology/20%Daily2017-11-15 00:00
https://www.clinicaltrialsarena.com/news/boehringer-lilly-report-positive-trial-data-jardiance/20%Daily2017-11-15 00:00
https://www.clinicaltrialsarena.com/news/akcea-launches-phase-ii-programme-rare-hyperlipidemias/20%Daily2021-11-26 04:19
https://www.clinicaltrialsarena.com/news/full-service-outsourcing-reviewing-the-successes-and-learnings-from-a-collaboration-in-action-5971227-2/20%Daily2018-07-18 12:17
https://www.clinicaltrialsarena.com/news/riboquark-starts-enrolment-phase-iiiii-trial-qpi-1007-china/20%Daily2017-11-14 00:00
https://www.clinicaltrialsarena.com/news/beigene-starts-two-lymphoma-trials-bgb-3111/20%Daily2017-11-14 00:00
https://www.clinicaltrialsarena.com/news/nektar-bms-report-data-phase-iii-oncology-trial/20%Daily2017-11-14 00:00
https://www.clinicaltrialsarena.com/news/redhill-biopharma-concludes-enrolment-crohns-disease-trial/20%Daily2017-11-13 00:00
https://www.clinicaltrialsarena.com/news/arena-pharma-completes-enrolment-phase-ii-trial-etrasimod/20%Daily2017-11-13 00:00
https://www.clinicaltrialsarena.com/news/bavarian-nordic-starts-phase-ii-booster-study-rsv-vaccine/20%Daily2017-11-13 00:00
https://www.clinicaltrialsarena.com/news/making-the-breakthrough-in-china-a-case-study-5968637-2/20%Daily2018-09-18 14:56
https://www.clinicaltrialsarena.com/news/astellas-begins-phase-ib-combination-trial-urothelial-cancer/20%Daily2021-10-28 12:28
https://www.clinicaltrialsarena.com/news/gsk-reports-long-term-data-benlystas-study-sle/20%Daily2017-11-10 00:00
https://www.clinicaltrialsarena.com/news/deals-week-horama-voyager-therapeutics-fibrocell-science/20%Daily2017-11-10 00:00
https://www.clinicaltrialsarena.com/news/mas-week-yifan-pharmaceutical-bioclinica/20%Daily2017-11-10 00:00
https://www.clinicaltrialsarena.com/comment/top-ten-investigated-monoclonal-antibodies/20%Daily2017-11-09 10:01
https://www.clinicaltrialsarena.com/news/8-ways-to-retain-your-talent-4911800-2/20%Daily2018-07-18 10:48
https://www.clinicaltrialsarena.com/news/alnylam-launches-phase-iii-trial-acute-hepatic-porphyrias/20%Daily2017-11-09 00:00
https://www.clinicaltrialsarena.com/news/novartiss-breast-cancer-drug-meets-phase-iii-primary-endpoint/20%Daily2017-11-09 00:00
https://www.clinicaltrialsarena.com/news/4-things-to-consider-which-will-improve-your-relationship-with-vendors-5967195-2/20%Daily2018-07-18 12:14
https://www.clinicaltrialsarena.com/news/debiopharm-begins-dosing-phase-ib-solid-tumours-trial/20%Daily2017-11-08 00:00
https://www.clinicaltrialsarena.com/news/janssens-stelara-reduces-lupus-disease-activity-phase-ii-trial/20%Daily2017-11-08 00:00
https://www.clinicaltrialsarena.com/news/octobers-top-news-stories/20%Daily2017-11-07 12:48
https://www.clinicaltrialsarena.com/news/unlocking-the-potential-of-risk-based-monitoring-in-oncology-clinical-trials-5966647-2/20%Daily2018-07-18 12:13
https://www.clinicaltrialsarena.com/news/uk-scientists-assess-ovarian-cancer-drug-brain-tumours/20%Daily2017-11-07 00:00
https://www.clinicaltrialsarena.com/news/new-us-trial-shows-safety-blood-plasma-infusions-alzheimers/20%Daily2017-11-07 00:00
https://www.clinicaltrialsarena.com/news/the-top-5-october-2017-5965529-2/20%Daily2018-12-12 10:44
https://www.clinicaltrialsarena.com/news/roswell-park-starts-oncology-trial-adoptive-t-cell-therapy/20%Daily2017-11-06 00:00
https://www.clinicaltrialsarena.com/news/biomarck-pharma-doses-first-patient-phase-ii-trial-ards/20%Daily2017-11-06 00:00
https://www.clinicaltrialsarena.com/news/phasebio-begins-pb1046-dosing-pulmonary-hypertension-study/20%Daily2017-11-03 00:00
https://www.clinicaltrialsarena.com/news/mylan-reports-positive-phase-iii-data-revefenacin-copd/20%Daily2017-11-03 00:00
https://www.clinicaltrialsarena.com/comment/real-world-evidence-personalised-medicine-ms/20%Daily2017-11-02 16:53
https://www.clinicaltrialsarena.com/comment/ozanimod-phase-iii-data-better-efficacy-interferon-rrms/20%Daily2017-11-02 16:39
https://www.clinicaltrialsarena.com/comment/surprisingly-good-phase-ii-results-ibudilast-progressive-ms/20%Daily2021-12-02 12:02
https://www.clinicaltrialsarena.com/comment/base-editing-programming-building-blocks-life/20%Daily2017-11-02 14:55
https://www.clinicaltrialsarena.com/news/industry-viewpoints-non-diluted-funding-in-preclinical-research-part-i-5963373-2/20%Daily2018-07-18 12:12
https://www.clinicaltrialsarena.com/news/cristal-studies-cripec-docetaxel-phase-ib-oncology-programme/20%Daily2017-11-02 00:00
https://www.clinicaltrialsarena.com/news/incyte-astrazeneca-begin-phase-iii-trial-nsclc/20%Daily2017-11-02 00:00
https://www.clinicaltrialsarena.com/comment/drug-developing-prospects-dry-age-related-macular-degeneration/20%Daily2017-11-01 12:06
https://www.clinicaltrialsarena.com/comment/bright-pharma-future-friendly-bacteria/20%Daily2017-11-01 11:38
https://www.clinicaltrialsarena.com/comment/biological-warfare-bacteria-answer-curtailing-arbovirus-transmission/20%Daily2017-11-01 10:57
https://www.clinicaltrialsarena.com/news/successfully-managing-your-study-tips-on-how-to-involve-your-vendor-for-optimized-results-5947867-2/20%Daily2018-07-18 12:10
https://www.clinicaltrialsarena.com/news/can-fite-enrolment-phase-iii-rheumatoid-arthritis-trial/20%Daily2017-11-01 00:00
https://www.clinicaltrialsarena.com/news/chi-med-starts-phase-iii-trial-fruquintinib-gastric-cancer/20%Daily2017-11-01 00:00